During the past decade, Southern Ohio Medical Center Cancer Center conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 16 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 2 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Southern Ohio Medical Center Cancer Center" #1 sponsor was "Alliance for Clinical Trials in Oncology" with 10 trials, followed by "SWOG Cancer Research Network" with 6 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 2 trials sponsored, "Eastern Cooperative Oncology Group" with 2 trials sponsored and "Radiation Therapy Oncology Group" with 2 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Southern Ohio Medical Center Cancer Center" #1 collaborator was "National Cancer Institute (NCI)" with 21 trials as a collaborator, "Bristol-Myers Squibb" with 2 trials as a collaborator, "Aptuit" with 1 trials as a collaborator, "Cancer and Leukemia Group B" with 1 trials as a collaborator and "Mayo Clinic" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 8 trials.

According to Clinical.Site data, the most researched conditions in "Southern Ohio Medical Center Cancer Center" are "Breast Cancer" (7 trials), "Pain" (3 trials), "Prostate Cancer" (3 trials), "Brain and Central Nervous System Tumors" (2 trials) and "Cancer Survivor" (2 trials). Many other conditions were trialed in "Southern Ohio Medical Center Cancer Center" in a lesser frequency.

Most popular intervention types in "Southern Ohio Medical Center Cancer Center" are "Drug" (13 trials), "Other" (6 trials), "Biological" (5 trials), "Radiation" (4 trials) and "Behavioral" (3 trials). Other intervention types were less common.

The name of intervention was led by "bevacizumab" (4 trials), "placebo" (4 trials), "cetuximab" (2 trials), "cisplatin" (2 trials) and "fluorouracil" (2 trials). Other intervention names were less common.

The vast majority of trials in "Southern Ohio Medical Center Cancer Center" are 13 trials for "All" genders, 5 trials for "Female" genders and 3 trials for "Male" genders.

Currently, there are NaN active trials in "Southern Ohio Medical Center Cancer Center". undefined are not yet recruiting, undefined are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 17 completed trials in Southern Ohio Medical Center Cancer Center, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Southern Ohio Medical Center Cancer Center, 1 "Phase 1" clinical trials were conducted, 9 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".